Haagsma EB - Search Results

1

Verdonk RC, van den Berg AP, Slooff MJ, Porte RJ, Haagsma EB. Verdonk RC, et al. Among authors: haagsma eb. Neth J Med. 2007 Nov;65(10):372-80. Neth J Med. 2007. PMID: 18057459 Free article. Review.

2

Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation.

van den Berg AP, Klompmaker IJ, Hepkema BG, Gouw AS, Haagsma EB, Lems SP, The TH, Slooff MJ. van den Berg AP, et al. Among authors: haagsma eb. Transpl Int. 1996;9 Suppl 1:S171-3. doi: 10.1007/978-3-662-00818-8_42. Transpl Int. 1996. PMID: 8959818

3

Donor-specific hyporeactivity after liver transplantation: prominent decreases in donor-specific cytotoxic T lymphocyte precursor frequencies independent of changes in helper T lymphocyte precursor frequencies or suppressor cell activity.

de Haan A, van den Berg AP, Hepkema BG, van Dijk E, Haagsma EB, The TH, Slooff MJ, Lems SP, de Leij LF, Prop J. de Haan A, et al. Among authors: haagsma eb. Transplantation. 1998 Aug 27;66(4):516-22. doi: 10.1097/00007890-199808270-00017. Transplantation. 1998. PMID: 9734497

4

Bone mineral density in the long term after liver transplantation.

Hamburg SM, Piers DA, van den Berg AP, Slooff MJ, Haagsma EB. Hamburg SM, et al. Among authors: haagsma eb. Osteoporos Int. 2000;11(7):600-6. doi: 10.1007/s001980070081. Osteoporos Int. 2000. PMID: 11069194

5

Increased cancer risk after liver transplantation: a population-based study.

Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ, Slooff MJ, Jansen PL. Haagsma EB, et al. J Hepatol. 2001 Jan;34(1):84-91. doi: 10.1016/s0168-8278(00)00077-5. J Hepatol. 2001. PMID: 11211912

6

Rapid decreases in donor-specific cytotoxic T lymphocyte precursor frequencies and graft outcome after liver and lung transplantation.

de Haan A, van den Berg AP, van der Bij W, Hepkema BG, Bruin-van Dijk E, van der Gun I, Lems SP, Slooff MJ, Haagsma EB, de Leij LF, Prop J. de Haan A, et al. Among authors: haagsma eb. Transplantation. 2001 Mar 27;71(6):785-91. doi: 10.1097/00007890-200103270-00017. Transplantation. 2001. PMID: 11330543

7

Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens.

Haagsma EB, Van Den Berg AP, Kleibeuker JH, Slooff MJ, Dijkstra G. Haagsma EB, et al. Aliment Pharmacol Ther. 2003 Jul 1;18(1):33-44. doi: 10.1046/j.1365-2036.2003.01613.x. Aliment Pharmacol Ther. 2003. PMID: 12848624

8

Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease.

Verdonk RC, Dijkstra G, Haagsma EB, Shostrom VK, Van den Berg AP, Kleibeuker JH, Langnas AN, Sudan DL. Verdonk RC, et al. Among authors: haagsma eb. Am J Transplant. 2006 Jun;6(6):1422-9. doi: 10.1111/j.1600-6143.2006.01333.x. Am J Transplant. 2006. PMID: 16686766 Free article.

9

Current health status of patients who have survived for more than 15 years after liver transplantation.

de Kroon L, Drent G, van den Berg AP, Haagsma EB; Liver Transplant Group Groningen. de Kroon L, et al. Among authors: haagsma eb. Neth J Med. 2007 Jul-Aug;65(7):252-8. Neth J Med. 2007. PMID: 17675671 Free article.

10

Long-term results after liver transplantation in adults.

Haagsma EB, Klompmaker IJ, Verwer R, Slooff MJ. Haagsma EB, et al. Scand J Gastroenterol Suppl. 1991;188:38-43. doi: 10.3109/00365529109111228. Scand J Gastroenterol Suppl. 1991. PMID: 1775940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters